HRT3 Activators
HRT3 Activators is a term used to describe a class of chemical compounds that are primarily associated with their role in modulating a specific receptor system within the human body. The acronym HRT3 stands for Hormone Receptor Type 3, which indicates their primary target – a subset of hormone receptors found in various tissues and cells. These activators are designed to bind to and influence the activity of Hormone Receptor Type 3, thereby impacting the downstream signaling pathways and physiological responses associated with this receptor.
The chemical structure and properties of HRT3 Activators can vary widely, as they encompass a diverse range of compounds, including synthetic molecules and natural substances. These compounds are specifically designed to interact with the HRT3 receptor in a way that can either enhance or inhibit its activity. Through their interaction with the receptor, HRT3 Activators can influence various cellular processes and gene expression, leading to a wide range of physiological effects. Understanding the molecular mechanisms of HRT3 Activators and their impact on Hormone Receptor Type 3 is a subject of ongoing research in the field of biochemistry and pharmacology. Scientists are continually exploring the potential applications and implications of these compounds, particularly in the context of hormonal signaling and cellular responses.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
γ-Secretase Inhibitor; May indirectly activate HRT3 by inhibiting Notch Signaling Pathway. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Wnt Agonist; May indirectly activate HRT3 by activating the Wnt Signaling Pathway. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC Inhibitor; Could indirectly increase HRT3 expression by epigenetic modulation. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome Inhibitor; May indirectly activate HRT3 by affecting its stability. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K Inhibitor; Could indirectly activate HRT3 via the PI3K/Akt Pathway. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β Receptor Inhibitor; May indirectly activate HRT3 by affecting TGF-β Signaling. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB Inhibitor; Could indirectly activate HRT3 by modulating the NF-κB Pathway. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
STAT3 Inhibitor; May indirectly activate HRT3 through the JAK/STAT Pathway. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Calcineurin Inhibitor; May indirectly activate HRT3 through the NFAT Signaling Pathway. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AMPK Activator; May indirectly activate HRT3 via the AMPK Pathway. | ||||||